Dr Camila Esguerra and her group use zebrafish as a model to study brain function in health and disease. In this profile piece, Camila discusses her research career to date, the benefits of using zebrafish in translational research, and her visions and plans for the future.
Dr Emma Haapaniemi joined NCMM as a group leader in January 2019. Her research programme will focus on rare immune diseases caused by genetics and rare acquired autoimmune diseases.
Professor Janna Saarela joined NCMM as Director in January 2019. She was previously head of the Technology Centre and Deputy Director of the Institute for Molecular Medicine Finland (FIMM), which is also part of the Nordic EMBL Partnership. Here she shares some insight into her research, and what she hopes the future holds for NCMM.
- New publication for the Mathelier Group: update to the JASPAR database Nov. 12, 2019 1:31 PM
- NCMM hosts annual PhD course in molecular medicine Nov. 11, 2019 2:34 PM
- Group led by Dr Camila Esguerra extended for four years Nov. 8, 2019 1:00 PM